Tr. Ivanov et al., IMIDAZOLINE RECEPTOR PROTEINS ARE REGULATED IN PLATELET-PRECURSOR MEG-01 CELLS BY AGONISTS AND ANTAGONISTS, Journal of Psychiatric Research, 32(2), 1998, pp. 65-79
The I-1-imidazoline receptor is a novel brainstem modulator of sympath
etic outflow that is elevated on platelets and in brains of depressed
patients. A positive correlation has been reported (accompanying manus
cript) between plasma norepinephrine (NE) concentrations and the densi
ties (B-max) of platelet I-1 binding sites (I-1 sites). I-1-candidate
proteins of 33 kDa and 85 kDa are now identified on Western blots prob
ed with anti-imidazoline receptor antiserum (IRBP antiserum), that cor
relate with B-max values for I-1 sites. Furthermore, a human megakaryo
blastoma cell line (MEG-OI) has been used to study the regulation of t
hese proteins on megakaryocytic cells, while bovine adrenal chromaffin
cells provide a standard I, cell type for comparison. Both the 33 kDa
and 85 kDa IRBP-immunoreactive bands were enriched in plasma membrane
fractions. IRBP antiserum did not cross-react with I, imidazoline bin
ding sites located on platelet mitochondrial membranes. The 85 kDa ban
d was enhanced under conditions lacking fetal bovine serum (FBS) from
the culture medium 6 h prior to harvesting. Conversely, 33 kDa protein
was enhanced on MEG-OI cells grown in the presence of 10%FBS; suggest
ing that a precursor (85 kDa) and product (33 kDa) relationship might
be induced by serum. The 85 kDa band was robustly up-regulated in resp
onse to imidazoline receptor-sensitive ligands; moxonidine, idazoxan a
nd agmatine(10 mu M each for 6 h). NE also up-regulated the 85 kDa IRB
P-immunoreactive protein on MEG-OI membranes, but to a lesser extent.
Idazoxan, an imidazoline alpha(2)-antagonist, off-set its induction of
85 kDa protein by reducing the 33 kDa band. Yohimbine, a non-imidazol
ine alpha(2)-antagonist, was ineffective alone, or in combination with
moxonidine (up to 40 mu M): but yohimbine blocked NE's induction of t
he 85 kDa band. Therefore. a rise in either plasma NE and/or endogenou
s I-site ligands (i.e, agmatine) could explain an elevation of imidazo
line receptors observed in depression. (C) 1998 Elsevier Science Ltd.
All rights reserved.